Locations:
Search IconSearch
December 19, 2018/Opinion

How AI Could Help Your Bad Back

Media Contact

Cleveland Clinic News Service | 216.444.0141

We’re available to shoot custom interviews & b-roll for media outlets upon request.

Media Downloads

CCNS health and medical content is consumer-friendly, professional broadcast quality (available in HD), and available to media outlets each day.

Anatomy of a man showing back pain

Cleveland Clinic’s Thomas E. Mroz, M.D., and Ghaith Habboub explain how artificial intelligence can help those with back pain, on the website of Scientific American:

“(T)he spine is a tricky and complicated region of the body. Several different conditions and diseases can affect the spine, resulting in a wide range of procedures used to treat them. Factor in the experience, expertise and pedigree of treating physicians; the wide variations in the utilization of pre- and post-operative resources; and a slew of patient-specific factors that may arise, and you end up with a swirling tempest of confusion—with the patient in the eye of the storm.

While the spine community has a wealth of knowledge in peer-reviewed medical literature, it remains extremely difficult, if not impossible, for the practicing physician or surgeon to reconcile in real time all of the data that will ultimately determine the most cost-effective choice for a particular treatment.

Fortunately, a solution is within our grasp. At Cleveland Clinic, and elsewhere, we are taking steps to leverage AI.”

Read the entire piece at Scientific AmericanHow AI Could Help Your Bad Back

Latest from the Newsroom

Beri Ridgeway, M.D.

Cleveland Clinic Appoints Beri Ridgeway, M.D., as President of Cleveland Clinic London

Genediting Therapy Shows Success Against Severe Sickle Cell Disease

Gene Editing Therapy Shows Success Against Severe Sickle Cell Disease

Cleveland Clinic's Main Campus lobby

Mandel Foundation Donates $50 Million to Improve Access to Care at Cleveland Clinic

Blood pressure cuff

Experimental Monthly Injectable Reduces a Key Regulator of Blood Pressure

GLP-1 injection pen with a stethoscope

Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease

Hospital Care At Home

Cleveland Clinic Introduces Hospital Care At Home in Ohio

Image of a scaled and tape measure

What Happens When Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic Study Reveals Real World Insights

Illustration of digital medical records

AI-Driven Chart Review Accurately Identifies Potential Rare Disease Trial Participants in New Study